<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="http://www.npr.org/rss/" xmlns:nprml="http://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>FDA </title>
    <link>http://www.npr.org</link>
    <description>FDA </description>
    <language>en</language>
    <copyright>Copyright 2013 NPR - For Personal Use Only</copyright>
    <generator>NPR API RSS Generator 0.94</generator>
    <lastBuildDate>Tue, 30 Apr 2013 15:51:00 -0400</lastBuildDate>
    <image>
      <url>http://media.npr.org/images/podcasts/thumbnail/npr_generic_image_75.jpg</url>
      <title>FDA </title>
      <link>http://www.npr.org</link>
    </image>
    <itunes:block>yes</itunes:block>
    <itunes:image href="http://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg"/>
    <item>
      <title>Caffeine-Laced Gum Has Energized The FDA</title>
      <description>Wrigley's new caffeinated gum has raised eyebrows at the FDA, which is worried about the potential health impacts on children and teens.</description>
      <pubDate>Tue, 30 Apr 2013 15:51:00 -0400</pubDate>
      <link>http://www.npr.org/blogs/thesalt/2013/04/30/180063432/caffeine-laced-gum-has-energized-the-fda?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/thesalt/2013/04/30/180063432/caffeine-laced-gum-has-energized-the-fda?ft=1&amp;f=136707520</guid>
      <itunes:summary>Wrigley's new caffeinated gum has raised eyebrows at the FDA, which is worried about the potential health impacts on children and teens.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>Wrigley's new caffeinated gum has raised eyebrows at the FDA, which is worried about the potential health impacts on children and teens.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=180063432">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D180063432">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
    <item>
      <title>Raw Milk Proponents Don't Trust Health Officials</title>
      <description>Public health officials will have a hard time convincing raw milk  advocates that the product is dangerous, according to a new study.</description>
      <pubDate>Mon, 05 Mar 2012 12:33:00 -0500</pubDate>
      <link>http://www.npr.org/blogs/thesalt/2012/03/05/147964638/raw-milk-proponents-dont-trust-health-officials?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/thesalt/2012/03/05/147964638/raw-milk-proponents-dont-trust-health-officials?ft=1&amp;f=136707520</guid>
      <itunes:summary>Public health officials will have a hard time convincing raw milk  advocates that the product is dangerous, according to a new study.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>Public health officials will have a hard time convincing raw milk  advocates that the product is dangerous, according to a new study.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=147964638">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D147964638">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
    <item>
      <title>Sprouts Growers Say They Need FDA To Set New Safety Rules</title>
      <description>With yet another outbreak of sprout-related illness, sprouts growers they need the FDA to provide new rules so they can test new techniques for reducing risk.</description>
      <pubDate>Fri, 17 Feb 2012 16:35:00 -0500</pubDate>
      <link>http://www.npr.org/blogs/thesalt/2012/02/17/147044294/sprouts-growers-say-they-need-fda-to-set-new-safety-rules?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/thesalt/2012/02/17/147044294/sprouts-growers-say-they-need-fda-to-set-new-safety-rules?ft=1&amp;f=136707520</guid>
      <itunes:summary>With yet another outbreak of sprout-related illness, sprouts growers they need the FDA to provide new rules so they can test new techniques for reducing risk.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>With yet another outbreak of sprout-related illness, sprouts growers they need the FDA to provide new rules so they can test new techniques for reducing risk.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=147044294">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D147044294">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
    <item>
      <title>Latest Drug Shortage Threatens Children With Leukemia</title>
      <description>Many hospitals around the nation are perilously close to running out of a form of the old standby cancer drug methotrexate. The reason: a principal supplier of injectable methotrexate shut down in November after it flunked an FDA inspection.</description>
      <pubDate>Thu, 16 Feb 2012 00:01:00 -0500</pubDate>
      <link>http://www.npr.org/blogs/health/2012/02/16/146960417/latest-drug-shortage-threatens-children-with-leukemia?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/health/2012/02/16/146960417/latest-drug-shortage-threatens-children-with-leukemia?ft=1&amp;f=136707520</guid>
      <itunes:summary>Many hospitals around the nation are perilously close to running out of a form of the old standby cancer drug methotrexate. The reason: a principal supplier of injectable methotrexate shut down in November after it flunked an FDA inspection.</itunes:summary>
      <itunes:keywords/>
      <itunes:duration>202</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>Many hospitals around the nation are perilously close to running out of a form of the old standby cancer drug methotrexate. The reason: a principal supplier of injectable methotrexate shut down in November after it flunked an FDA inspection.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=146960417">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D146960417">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
      <enclosure url="http://public.npr.org/anon.npr-mp3/npr/me/2012/02/20120216_me_11.mp3?sc=16&amp;orgId=1&amp;forsearch=0&amp;topicId=1128&amp;ft=1&amp;f=136707520" length="100000" type="audio/mpeg"/>
    </item>
    <item>
      <title>Birth Control Pill Mix-Up Leads To Pfizer Recall</title>
      <description>Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.</description>
      <pubDate>Wed, 01 Feb 2012 10:20:00 -0500</pubDate>
      <link>http://www.npr.org/blogs/health/2012/02/01/146195972/birth-control-pill-mix-up-leads-to-pfizer-recall?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/health/2012/02/01/146195972/birth-control-pill-mix-up-leads-to-pfizer-recall?ft=1&amp;f=136707520</guid>
      <itunes:summary>Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=146195972">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D146195972">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
    <item>
      <title>Efforts Founder To Track Long-Term Safety Of Silicone Breast Implants</title>
      <description>Manufacturers of silicone breast implants have done such a poor job of tracking patients that it's impossible to know if the devices have long-term health and safety risks, consumer advocates said a meeting of experts advising the Food and Drug Administration.</description>
      <pubDate>Thu, 01 Sep 2011 15:07:00 -0400</pubDate>
      <link>http://www.npr.org/blogs/health/2011/09/01/140116414/efforts-to-track-long-term-safety-of-silicone-breast-implants-flounder?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/health/2011/09/01/140116414/efforts-to-track-long-term-safety-of-silicone-breast-implants-flounder?ft=1&amp;f=136707520</guid>
      <itunes:summary>Manufacturers of silicone breast implants have done such a poor job of tracking patients that it's impossible to know if the devices have long-term health and safety risks, consumer advocates said a meeting of experts advising the Food and Drug Administration.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>Manufacturers of silicone breast implants have done such a poor job of tracking patients that it's impossible to know if the devices have long-term health and safety risks, consumer advocates said a meeting of experts advising the Food and Drug Administration.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=140116414">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D140116414">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
    <item>
      <title>Scorpion Venom Meets Its Match</title>
      <description>The Food and Drug Administration has approved the first antivenom against scorpion toxin. Called Anascorp, the treatment was developed in Mexico and will cost more than $10,000 per patient. For small children, who are at greatest risk from the bites, the treatment can be life-saving.</description>
      <pubDate>Thu, 04 Aug 2011 16:29:00 -0400</pubDate>
      <link>http://www.npr.org/blogs/health/2011/08/06/138993899/scorpion-venom-meets-its-match?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/health/2011/08/06/138993899/scorpion-venom-meets-its-match?ft=1&amp;f=136707520</guid>
      <itunes:summary>The Food and Drug Administration has approved the first antivenom against scorpion toxin. Called Anascorp, the treatment was developed in Mexico and will cost more than $10,000 per patient. For small children, who are at greatest risk from the bites, the treatment can be life-saving.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>The Food and Drug Administration has approved the first antivenom against scorpion toxin. Called Anascorp, the treatment was developed in Mexico and will cost more than $10,000 per patient. For small children, who are at greatest risk from the bites, the treatment can be life-saving.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=138993899">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D138993899">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
    <item>
      <title>New Cigarette Labels Are Gruesome On Purpose</title>
      <description>The FDA's revamp of its anti-smoking campaign might make us a bit squeamish, but isn't that the point? The agency enlisted 18,000 people to help it pick the images that made people want to quit or never start smoking.</description>
      <pubDate>Tue, 21 Jun 2011 17:35:00 -0400</pubDate>
      <link>http://www.npr.org/blogs/health/2011/06/22/137328307/new-cigarette-labels-are-gruesome-on-purpose?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/health/2011/06/22/137328307/new-cigarette-labels-are-gruesome-on-purpose?ft=1&amp;f=136707520</guid>
      <itunes:summary>The FDA's revamp of its anti-smoking campaign might make us a bit squeamish, but isn't that the point? The agency enlisted 18,000 people to help it pick the images that made people want to quit or never start smoking.</itunes:summary>
      <itunes:keywords/>
      <itunes:duration>75</itunes:duration>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>The FDA's revamp of its anti-smoking campaign might make us a bit squeamish, but isn't that the point? The agency enlisted 18,000 people to help it pick the images that made people want to quit or never start smoking.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=137328307">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D137328307">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
      <enclosure url="http://public.npr.org/anon.npr-mp3/npr/atc/2011/06/20110621_atc_04.mp3?sc=16&amp;orgId=1&amp;forsearch=0&amp;topicId=1128&amp;ft=1&amp;f=136707520" length="100000" type="audio/mpeg"/>
    </item>
    <item>
      <title>Curbs On Ads For New Drugs Could Be A Mixed Bag</title>
      <description>The value of a moratorium on consumer ads for new drugs would hinge on whether a reduction in unexpected side effects outweighed lost health benefits from reduced use of effective medicines, a Congressional Budget Office report says.</description>
      <pubDate>Fri, 27 May 2011 08:36:00 -0400</pubDate>
      <link>http://www.npr.org/blogs/health/2011/05/27/136707432/curbs-on-ads-for-new-drugs-could-be-a-mixed-bag?ft=1&amp;f=136707520</link>
      <guid>http://www.npr.org/blogs/health/2011/05/27/136707432/curbs-on-ads-for-new-drugs-could-be-a-mixed-bag?ft=1&amp;f=136707520</guid>
      <itunes:summary>The value of a moratorium on consumer ads for new drugs would hinge on whether a reduction in unexpected side effects outweighed lost health benefits from reduced use of effective medicines, a Congressional Budget Office report says.</itunes:summary>
      <itunes:keywords/>
      <itunes:explicit>no</itunes:explicit>
      <content:encoded><![CDATA[<p>The value of a moratorium on consumer ads for new drugs would hinge on whether a reduction in unexpected side effects outweighed lost health benefits from reduced use of effective medicines, a Congressional Budget Office report says.</p><p><a href="http://www.npr.org/templates/email/emailAFriend.php?storyId=136707432">&raquo; E-Mail This</a>&nbsp;&nbsp;&nbsp;&nbsp; <a href="http://del.icio.us/post?url=http%3A%2F%2Fwww.npr.org%2Ftemplates%2Fstory%2Fstory.php%3FstoryId%3D136707432">&raquo; Add to Del.icio.us</a></p>]]></content:encoded>
    </item>
  </channel>
</rss>
